BCR-ABL oncoprotein is expressed by platelets from CML patients and associated with a special pattern of CrKL phosphorylation

British Journal of Haematology

Volumn 103, Issue 4, 1998, Pages 1109-1115

  Ten Bosch, George J A ^a   Kessler, Jan H ^a   Blom, Johanna ^a   Joosten, Antonia M ^a   Gambacorti Passerini, Carlo ^b   Melief, Cornelis J M ^a   Leeksma, Onno C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

BCR ABL; CML; CrkL; Platelets

Indexed keywords

BCR ABL PROTEIN;

ADULT; AGED; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; GENETIC ANALYSIS; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; THROMBOCYTOSIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; BLOOD PLATELETS; BLOTTING, WESTERN; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; SENSITIVITY AND SPECIFICITY;

EID: 0032424910     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.01115.x     Document Type: Article

References (36)

1. Ahmad, S., Alsayed, Y.M., Druker, B.J. & Platanias, L.C. (1997) The type I interferon receptor mediates tyrosine phosphorylation of the Crkl adaptor protein. Journal of Biological Chemistry, 272, 29991-29994.
2. Andoniou, C.E., Thien, C.B. & Langdon, W.Y. (1994) Tumour induction by activated ABL involves tyrosine phosphorylation of the product of the Cbl oncogene. EMBO Journal, 13, 4515-4523.
3. Castellanos, A., Pintado, B., Weruaga, E., Arevalo, R., Lopez, A., Orfao, A. & Sanchez-Garcia, I. (1997) A BCR-ABL(p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous her product. Blood, 90, 2168-2174.
4. Daley, G.Q., van Etten, R.A. & Baltimore, D. (1990) Induction of chronic myelogenous leukemia in mice by the p210BCR-ABL gene of the Philadelphia chromosome. Science, 247, 824-830.
5. de Jong, R., ten Hoeve, J., Heisterkamp, N. & Groffen, J. (1997a) Tyrosine 207 in CrkL is the BCR/ABL phosphorylation site. Oncogene, 14, 507-513.
6. de Jong, R., van Wijk, A., Haataja, L., Heisterkamp, N. & Groffen, J. (1997b) Bcr/abl-induced leukemogenesis causes phosphorylation of HEF1 and its association with CRKL. Journal of Biological Chemitry, 272, 32649-32655.
7. Druker, B.J., Tamura, S., Buchudunger, E., Ohno, S., Segal, G.M., Fanning, S., Zimmermann, J. & Lydon, N.B. (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of BCR-Abl positive cells. Nature Medicine, 2, 561-566.
8. Emilia, G., Luppi, M., Marasca, R. & Torelli, G. (1997) Relationship between BCR/ABL fusion proteins and leukemia phenotype. Blood, 89, 3889.
9. Fialkow, P.J., Jacobson, R.J. & Papayannopoulu, T. (1977) Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. American Journal of Medicine, 63, 125-130.
10. Gaiger, A., Henn, T. Horth, E., Geissler, K., Mitterbauer, G., Maier-Dobersberger, T., Greinix, H., Mannhalter, C., Haas, O.A., Lechler, K. & Lion, T. (1995) Increase of BCR-ABL chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression. Blood, 86, 2371-2378.
11. Gishizky, M. & Witte, O.N. (1992) Initiation of deregulated growth of multipotent progenitor cells by bcr/abl in vitro. Science, 256, 836-839.
12. Guerrasio, A., Serra, A., Gottardi, E., Cilloni, D., Vischia, F., Parvis, G., Cilli, V. & Saglio, G. (1997) Molecular events in chronic myeloid leukemia progression. Leukemia, 11, (Suppl. 3), 519-521.
13. Harrison, P., Wilbourn, B., Debili, N., Vainchenker, W., Breton-Giorius, J., Lawrie, A.S., Masse, J.M., Savidge, F.G. & Cramer, E.M. (1989) Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets. Journal of Clinical Investigation, 84, 1320-1324.
14. Honda, H., Fujii, T. Takatoku, M., Mano, H., Witte, O.N., Yazaki, Y. & Hirai, H. (1995) Expression of p210bcr/abl by metallothionein promotor induced T-cell leukemia in transgenic mice. Blood, 85, 2853-2861.
15. Honda, H., Oda, H., Suzuki, T., Takahashi, T., Witte, O.N., Ozawa, K., Ishikawa, T., Yazaki, Y. & Hirai, H. (1988) Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210BCR/ABL: a novel transgenic model for human Phl-positive leukemias. Blood, 91, 2067-2075.
16. Konopka, J.B. & Witte, O.N. (1985) Detection of c-Abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Molecular and Cellular Biology, 5, 3116-5125.
17. Lugo, T.G., Pendergast, A., Muller, A.J. & Witte, O.N. (1990) Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science, 247, 1079-1082.
18. Maurer, J. & Thiel, E. (1991) PCR-based rapid detection of the Philadelphia chromosome in chronic myelogenous and acute lymphoblastic leukemia. PCR Topics: Usage of Polymerase Chain Reaction in Genetic and Infections Diseases (ed. by A. Rolfs, H. Chr. Schumacher and P. Marx), p. 254. Springer, Berlin.
19. Melo, J.V. (1996) The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood, 88, 2375-2384.
20. Melo, J.V. Myintm H., Galton, D.A. & Goldman, J.M. (1994) P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia? Leukemia, 8, 208-211.
21. Nichols, G.L., Raines, M.A., Vera, J.C., Lacomis, L., Tempst, P. & Golde, D.W. (1994) Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells. Blood, 84, 2912-2918.
22. Oda, T., Heaney, C., Hagopian, J.R., Okuda, K., Griffin, J.D. & Druker, B.J. (1994) Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia. Journal of Biological Chemistry, 269, 22925-22928.
23. Oda, A., Miyakawa, Y., Druker, B., Ishida, A., Ozaki, K., Hideya, O., Wakui, M., Handa, M., Wantanabe, K., Okamoto, S. & Ikeda, Y. (1996) Crkl is constitutively tyrosine phosphorylated in platelets from chronic myelogenous leukemia patients and inducibly phosphorylated in normal platelets stimulated by thrombopoietin. Blood, 88, 4304-4313.
24. Pane, F., Frigeri, E. Sindona, M., Luciano, L., Ferrara, F., Cimino, R., Meloni, G., Saglio, G., Salvatore, F. & Rotoli, B. (1996) Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR-ABL with C2A3 junction). Blood, 88, 2410-2414.
25. Saglia, R., Pisick, E., Sattler, M., Li, J.L., Hemura, N., Wong, W.K., Burky, S.A., Hirai, H., Chen, L.B. & Griffin, J.D. (1996) p13OCAS forms a signaling complex with the adapter protein CrkL in hematopoietic cells transformed by the BCR-ABL oncogene. Journal of Biological Chemistry, 271, 25198-25203.
26. Saglia, R., Uemura, N., Okuda, K., Li, J.L., Pisick, H., Sattler, M., de Jong, R., Druker, B., Heisterkamp, N., Chen, L.B., Groffen, J. & Griffin, J.D. (1995) CrkL links p210BCR-ABL with paxillin in chronic myelogenous leukemia cells. Journal of Biological Chemistry, 270, 29145-29150.
27. Saglio, G., Pane, F., Gottardi, E., Frigeri, F., Buonaiuto, M.R., Guerrasio, A., De Micheli, D., Parziale, A., Fornaci, M.N., Martinelli, G. & Salvatore, F. (1996) Consistent amounts of acute leukemia-associated p190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis. Blood, 87, 1075-1080.
28. Sattler, M. Salgia, R., Shrikhande, G., Verma, S., Piscik, E., Prasad, K. & Griffin, J.D. (1997) Steel factor induces tyrosine phosphor, ylation of Crkl and binding of Crkl to a complex containing c-Kit. phosphatidylinositol 3-kinase, and p120Cbl. Journal of Biological Chemistry, 272, 10248-10253.
29. Senechal, K., Halpern, J. & Sawyers, C.L. (1996) The CRKL adaptor protein transforms fibroblasts and functions in transformation by the BCR-ABL oncogene. Journal of Biological Chemistry, 271, 25255-23261.
30. Shtivelman, E., Lifshitz, B., Gale, R.P., Roe, B.A. & Canaani, E. (1986) Alternative splicing of RNAs transcribed from the human abl gene and from the BCR-ABL fused gene. Cell, 47, 277-284.
31. Smit, L., van der Horst, G. & Borst, J. (1995) Sos, Vav and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Gbr2, Crk, and Crk-L adaptors. Journal of Biological Chemistry, 271, 8564-8569.
32. + leukemia. Blood, 84, 1731-1736.
33. ten Hoeve, J., Kaartinen, V., Fioretos, T., Haataja, L., Voncken, J.W., Heisterkamp, N. & Groffen, J. (1994b) Cellular interactions of CRKL, an SH2-SH3 adaptor protein. Cancer Research, 54, 2563-2567.
34. Uemura, N., Salgia, R., Li, J.L., Pisick, E., Sattler, M. & Griffin, J.D. (1997) The BCR/ABL oncogene alters interaction of the adaptor proteins CRKL and CRK with cellular proteins. Leukemia, 11, 376-385.
35. van Rhee, F., Hochhaus, A., Lin, F., Melo, J.V., Goldman, J.M. & Cross, N.C.P. (1996) P190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias. Blood, 87, 5213-5221.
36. Voncken, J.W., Kaartinen, V., Pattengale, P.K., Germeraad, W.T., Groffen, J. & Heisterkamp, N. (1995) BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice. Blood, 86, 4603-4611.